ArticleProceedings of the National Academy of Sciences of the United States of America2025

DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden.

Jeong-Ryeol Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.